The leader of the new initiative, Tae Hyun Hwang, PhD, will work to apply AI and other revolutionary technologies, including advanced molecular imaging techniques, to clinical practice.

At neurology clinics the system was used to flag 8% of arriving patients as having relatively high risk for suicide attempt in the next 30 days.

Using AI, a team identified a gap in post-market drug safety: not all published reports of dangerous drug interactions are taken up by recognized purveyors of drug safety information.

His contributions to clinical systems, infrastructure and education have had a lasting impact not only here at Vanderbilt but across the entire field of informatics.

The highlighted efforts demonstrated commitment to expanding the use of advanced technology to serve patients.

Sponsored by the Department of Biomedical Informatics, the symposium showcased the work of the department’s center for AI Discovery and Vigilance to Accelerate Innovation and Clinical Excellence.

Under the old system, genetic counselors would complete paper requisitions, and results would return as PDFs that had to be manually uploaded into patients' electronic health records.